CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Levamisole and IsoprinosineWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (3)


Name (Synonyms) Correlation
drug1263 Isoprinosine Wiki 1.00
drug1334 Levamisole Wiki 1.00
drug1923 Prone positioning Wiki 0.58

Correlated MeSH Terms (1)


Name (Synonyms) Correlation
D018352 Coronavirus Infections NIH 0.04

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 Impact of Levamisole and Isoprinosine in Immune-prophylaxis of Egyptian Healthcare Workers Facing COVID-19

This randomized open labeled clinical trial will include one hundred healthy healthcare workers who will be randomly assigned into four groups of twenty-five each to receive either levamisole, Isoprinosine, combined levamisole and isoprinosine or no-intervention for two months to detect the impact of Levamisole and Isoprinosine as immune-prophylaxis on the incidence of COVID-19 infection. Participants will be followed-up for three months clinically and laboratory. Blood samples will be collected prior to randomization and during follow up.

NCT04360122 Coronavirus Disease (COVID-19) Drug: Levamisole Drug: Isoprinosine Drug: Levamisole and Isoprinosine
MeSH:Coronavirus Infections

Primary Outcomes

Description: Detect if Levamisole and Isoprinosine can decrease the incidence of COVID-19 infection

Measure: Decrease the incidence of COVID-19 infection or its severity

Time: 6 months


No related HPO nodes (Using clinical trials)